Nxera Pharma Co., Ltd.
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
4565 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区赤坂９−７−２
- Website:
- https://www.nxera.life/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Nxera Pharma Co., Ltd. (formerly Sosei Group) is a technology-driven biopharmaceutical company focused on the discovery and development of specialty medicines. Its mission is to accelerate the creation of life-changing treatments for patients with unmet medical needs, both in Japan and globally. The company leverages its proprietary structure-based drug design (SBDD) platform and drug development capabilities to advance a diverse pipeline of therapeutic programs. Nxera Pharma actively seeks partnerships to pursue breakthrough discoveries and bring innovative medicines to market, with a focus on areas such as neurology and gastroenterology.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Nxera Pharma Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-08 09:06 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 41.8 KB | |
| 2025-08-08 09:05 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 41.8 KB | |
| 2025-08-08 08:57 |
Regulatory News Service
確認書
|
Japanese | 8.4 KB | |
| 2025-08-08 08:55 |
Interim Report
半期報告書－第36期(2025/01/01－2025/12/31)
|
Japanese | 287.5 KB | |
| 2025-04-16 08:57 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 41.6 KB | |
| 2025-04-16 08:55 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 41.6 KB | |
| 2025-04-16 08:53 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 39.8 KB | |
| 2025-04-16 08:51 |
Regulatory News Service
臨時報告書
|
Japanese | 32.4 KB | |
| 2025-03-26 08:42 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 42.2 KB | |
| 2025-03-26 08:41 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 42.2 KB | |
| 2025-03-26 08:40 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 40.4 KB | |
| 2025-03-26 08:38 |
Regulatory News Service
臨時報告書
|
Japanese | 28.0 KB | |
| 2025-03-26 08:37 |
Regulatory News Service
内部統制報告書－第35期(2024/01/01－2024/12/31)
|
Japanese | 23.8 KB | |
| 2025-03-26 08:36 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
| 2025-03-26 08:35 |
Annual Report
有価証券報告書－第35期(2024/01/01－2024/12/31)
|
Japanese | 1.3 MB |
Automate Your Workflow. Get a real-time feed of all Nxera Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Nxera Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
